As a nuclear receptor, Nur77 has been shown to participate in the regulation of a variety of inflammatory diseases, and is differentially expressed in organs and tissues with chronic inflammation in both humans and animal models in vivo, and changes in its expression have been associated with different disease outcomes in various inflammatory disease models (Lith and de Vries, 2021). Here, NR4A1 is linked to inflammation.